James R. Gavin III, Director at AMYLIN PHARMACEUTICALS INC (AMLN), sold 670 shares at $14.94 ($10K) on 2011-01-18, disclosed to the SEC on 2011-02-15.
Open-market sale of $10k AMLN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BAX | SELL | 2018-03-30 | $2.3M | — | Filing → |
| BAX | SELL | 2017-03-30 | $443K | — | Filing → |
| BXLT | SELL | 2016-03-28 | $452K | — | Filing → |